Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.
Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas.
Ann Thorac Surg. 2019 Jun;107(6):1782-1789. doi: 10.1016/j.athoracsur.2018.10.077. Epub 2018 Dec 14.
Readmissions adversely affect hospital reimbursement and quality measures. We aimed to evaluate the incidence, cost, and risk factors for readmission following coronary artery bypass grafting (CABG).
We queried the National Readmissions Database and isolated patients who underwent CABG from 2013 to 2014. We determined the top reasons for readmission and compared demographics, comorbidities, in-hospital outcomes, and costs between readmitted and nonreadmitted patients. Generalized linear regression was performed to identify independent predictors for readmission.
We identified 288,059 patients who underwent isolated CABG in the United States between 2013 and 2014. A total of 12.2% were readmitted within 30 days of discharge. Postoperative infection, heart failure, and arrhythmia were the most common reasons for readmission. The median time to readmit was 11 days, with a length of stay (LOS) of 6 days and a cost of $13,499 ± $201. Independent preoperative predictors for readmission were Medicaid status (odds ratio [OR], 1.33), female sex (OR, 1.32), chronic renal failure (OR, 1.26), greater than 4 Elixhauser comorbidities (OR, 1.20), chronic pulmonary disease (OR, 1.15), and nonelective operation (OR, 1.10) (all p < 0.05). In-hospital predictors included LOS greater than 10 days (OR, 1.52), acute kidney injury (OR, 1.30), atrial fibrillation (OR, 1.20), pneumonia (OR, 1.13), and discharge to skilled nursing facility (OR, 1.43) (all p < 0.05).
Thirty-day readmissions after CABG are frequent and related to preoperative comorbidities and complex postoperative course. Medicaid status, prolonged LOS, and disposition to a skilled nursing facility are strong predictors for 30-day readmission following CABG. Readmission reduction efforts should consider improvements for patients in these cohorts.
再入院对医院的报销和质量措施有不利影响。我们旨在评估冠状动脉旁路移植术(CABG)后再入院的发生率、成本和危险因素。
我们查询了国家再入院数据库,并从中筛选出 2013 年至 2014 年间接受 CABG 的患者。我们确定了再入院的主要原因,并比较了再入院和非再入院患者的人口统计学特征、合并症、住院结局和费用。使用广义线性回归确定再入院的独立预测因素。
我们在美国确定了 2013 年至 2014 年间接受单独 CABG 的 288,059 名患者。出院后 30 天内再入院的比例为 12.2%。术后感染、心力衰竭和心律失常是再入院的最常见原因。再入院的中位时间为 11 天,住院时间(LOS)为 6 天,费用为 13,499±201 美元。再入院的独立术前预测因素包括医疗补助状态(比值比 [OR],1.33)、女性(OR,1.32)、慢性肾衰竭(OR,1.26)、大于 4 种 Elixhauser 合并症(OR,1.20)、慢性肺部疾病(OR,1.15)和非择期手术(OR,1.10)(均 p<0.05)。住院期间的预测因素包括 LOS 大于 10 天(OR,1.52)、急性肾损伤(OR,1.30)、心房颤动(OR,1.20)、肺炎(OR,1.13)和出院至熟练护理机构(OR,1.43)(均 p<0.05)。
CABG 后 30 天内再入院较为常见,与术前合并症和复杂的术后病程有关。医疗补助状态、LOS 延长和向熟练护理机构的处置是 CABG 后 30 天内再入院的强有力预测因素。减少再入院的努力应考虑改善这些患者群体的状况。